SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amerise Biosciences - Quaterly Results

08 Aug 2022 Evaluate
The Sales for the quarter ended June 2022 of Rs. 0.03 million declined by -99.80% from Rs. 14.91 millions.The Net Loss for the quarter ended June 2022 is Rs. -0.39 millions as compared to Net Profit of Rs. 2.96 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -0.39% as compared to 2.96% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 0.03 14.91 -99.80 0.03 14.91 -99.80 95.77 -1.69 -5766.86
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBIDT -0.39 2.96 -113.18 -0.39 2.96 -113.18 5.48 -3.37 -262.61
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.39 2.96 -113.18 -0.39 2.96 -113.18 5.48 -3.37 -262.61
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.39 2.96 -113.18 -0.39 2.96 -113.18 5.48 -3.37 -262.61
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.39 2.96 -113.18 -0.39 2.96 -113.18 5.48 -3.37 -262.61
Equity 66.07 66.07 0.00 66.07 66.07 0.00 66.07 66.07 0.00
PBIDTM(%) -1300.00 19.85 -6648.29 -1300.00 19.85 -6648.33 5.72 199.41 -97.13

Amerise Biosciences Share Price

0.72 0.03 (4.35%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×